Back to search
FDAFDA · Food and drugs·Recall number D-0182-2027

Metoprolol Tartrate Tablets, USP, 50 mg, 1,000 Tablets per bottle, Rx Only, Distributed by: Advagen Pharma Ltd., East Windsor, NJ 08520, USA. NDC: 72888-210-00.

Published November 11, 2026 · Recall initiated: October 27, 2026

Summary

FDA records drug Class II recall D-0182-2027, published November 11, 2026 and initiated October 27, 2026. Recalling firm: Advagen Pharma Limited; Status: Ongoing; Reported quantity: 3684 bottles; Lot: Batch#: 2611C065A1: Expiry: 05/2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules

What to do

Voluntary: Firm initiated · Letter

Get an email if METOPROLOL TARTRATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METOPROLOL TARTRATE
Manufacturer
Advagen Pharma Limited
Distributor
U.S. Nationwide
UPC
0372888212005
Lot
Batch#: 2611C065A1: Expiry: 05/2028
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Metoprolol Tartrate Tablets, USP, 50 mg, 1,000 Tablets per bottle, Rx Only, Distributed by: Advagen Pharma Ltd., East Windsor, NJ 08520, USA. NDC: 72888-210-00. recalled?

Yes. FDA published recall D-0182-2027 on November 11, 2026. Reported hazard: Presence of Foreign Tablets/Capsules

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METOPROLOL TARTRATE. UPC: 0372888212005.